Abstract:Background: Idiopathic pulmonary fibrosis (IPF) is a chronic and fatal pulmonary interstitial disease that usually occurs in the elderly. The senescence of alveolar epithelial cells (AECs) is an important mechanism of IPF. The AECs of patients with IPF have lower expression of peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha), which has been shown to play an important role in maintaining mitochondrial morphology and energy metabolism. This study sought to explore the mechanism by which ZLN005 improves mitochondrial function by upregulating PGC-1 alpha to protect AECs from aging.Methods: Western blot was used to detect the expression of PGC-1 alpha, mitochondrial synthesis protein nuclear respiratory factor-1 (NRF-1), and p21(WAF1) in the lung tissue of the IPF patients and the mice with bleomycin (BLM)-induced pulmonary fibrosis. A549 cells and mice AEC2 cells were treated with hydrogen peroxide (H2O2) to construct cell senescence models. Cell senescence was detected by senescence-associated beta-galactosidase staining. The mitochondrial respiratory function was measured, including the adenosine triphosphate (ATP) generation, reactive oxygen species (ROS) level, changes in cell membrane potential, and energy metabolism. Using lentivirus as a vector and using gene editing technology to over express (upPGC-1 alpha) and knockdown PGC-1 alpha (shPGC-1 alpha) in the A549 cells. The PGC-1 alpha agonist ZLN005 was used to pretreat the A549 and shPGC-1 alpha A549 cells, and cell aging and mitochondrial respiratory function were observed.Results: The Western blot and immunofluorescence assays showed that the expression of PGC-1 alpha and NRF-1 was decreased in the lung tissues of the IPF patients and BLM-induced mice pulmonary fibrosis model, while the expression of p21(WAF1 )was increased. The results of the immunofluorescence and mitochondrial function experiments also indicated that the expression of PGC-1 alpha and mitochondrial synthesis protein NRF-1 were decreased in the senescent cells. Further, the mitochondrial morphology was abnormal and the mitochondrial function was impaired. PGC-1 alpha was involved in the AEC senescence by regulating mitochondrial morphology and function. Treatment with the agonist of PGC-1 alpha (i.e., ZLN005) blocked the H2O2-induced cell senescence by enhancing the expression of PGC-1 alpha.Conclusions: These results provide preliminary insights into the potential clinical application of ZLN005 as a novel therapeutic agent for the treatment of IPF.

ZLN005, a PGC-1α Activator, Protects the Liver against Ischemia–Reperfusion Injury and the Progression of Hepatic Metastases

ZLN005 protects against ischemia-reperfusion-induced kidney injury by mitigating oxidative stress through the restoration of mitochondrial fatty acid oxidation

Activation of Cyclic Adenosine Monophosphate-Dependent Protein Kinase a Signaling Prevents Liver Ischemia/reperfusion Injury in Mice

Inhibition of wild-type p53-induced phosphatase 1 promotes liver regeneration in mice by direct activation of mammalian target of rapamycin.

Spatial transcriptomics analysis of zone-dependent hepatic ischemia-reperfusion injury murine model

ZLN005 improves the protective effect of mitochondrial function on alveolar epithelial cell aging by upregulating PGC-1α

The PGC-1α Activator ZLN005 Ameliorates Ischemia-Induced Neuronal Injury in Vitro and in Vivo

Exercise Preconditioning of the Donor Liver Decreases Cold Ischemia/Reperfusion Injury in a Mouse Model

ZLN005 Improves the Protective Effect of Mitochondrial Function on Alveolar Epithelial Cell Aging by Upregulating PGC-1

Synergy of 5-Aminolevulinate Supplement and CX3CR1 Suppression Promotes Liver Regeneration Via Elevated IGF-1 Signaling.

Prophylactical Low Dose Whole-Liver Irradiation Inhibited Colorectal Liver Metastasis by Regulating Hepatic Niche in Mice

Preoperative Exercise Therapy Protects the Liver from Ischemia-Reperfusion Injury

Lactobacillus rhamnosus HN001 facilitates the efficacy of dual PI3K/mTOR inhibition prolonging cardiac transplant survival and enhancing antitumor effect

Augmenter of Liver Regeneration-Mediated Mitophagy Protects Against Hepatic Ischemia/reperfusion Injury.

Allicin Attenuated Hepatic Ischemia/reperfusion Injury in Mice by Regulating PPARγ-IRAK-M-TLR4 Signal Pathway.

Mtor Activation Protects Liver from Ischemia/reperfusion‐induced Injury Through NF‐κB Pathway

ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury

Peptidomic Analysis Reveals that Novel Peptide LDP2 Protects Against Hepatic Ischemia/Reperfusion Injury

Abstract 13835: MG53 Preserves Mitochondrial Integrity of Cardiomyocytes in Pre-Clinical Models of Ischemia Reperfusion-Induced Oxidative Stress

The liver X receptor agonist TO901317 protects mice against cisplatin-induced kidney injury

Remodeling the hepatic immune microenvironment and demolishing T cell traps to enhance immunotherapy efficacy in liver metastasis